Why Choose Sleep Data As Your Care Partner?
You certainly have a number of referral options when you suspect patients have sleep apnea, but none of our competitors have our depth of experience and expertise. Here are a few reasons why so many physicians trust Sleep Data to diagnose and treat their sleep apnea patients:
- Clinicians who pioneered home sleep testing founded our company.
- Diagnostic tests are hand-scored by a registered polysomnographic technologist (RPSGT) and interpreted by a board-certified sleep physician.
- We offer a comprehensive program that can be utilized in its entirety—diagnosis through ongoing treatment—or you may choose to use any portion of it, e.g., just sending patients to us for supplies.
- Our in-depth reporting tools will keep you apprised of your patients’ treatment progress.
- We make it very simple for you to refer patients to us.
Sleep Data looks forward to being your care partner, enhancing your patients’ health and wellness by diagnosing and treating sleep apnea.
Sleep Data is the only resource you need to diagnose and treat your patients’ sleep apnea to improve their health, wellness, and quality of life. We welcome the opportunity to earn your trust by showcasing our professionalism and expertise so you are comfortable referring patients to us when you suspect they suffer from sleep apnea.
According to the New England Journal of Medicine, approximately 42 million American adults have sleep-disordered breathing (SDB), which describes four nocturnal breathing disorders:
Obstructive sleep apnea (OSA)
Central sleep apnea (CSA)
Cheyne-Stokes respiration (CSR)
PROUDLY SERVING ALL OF OUR CARE PARTNERS
AMONG MANY OTHERS
The Journal of the American Medical Association notes that 1 in 5 adults have mild OSA and 1 in 15 have moderate to severe cases. According to Sleep, 75% of severe SDB cases are undiagnosed.
The consequences of failing to treat sleep apnea can be deadly, since co-morbid diseases include cardiovascular issues, hypertension, type 2 diabetes and stroke:
of congestive heart failure patients have SDB (as per the European Journal of Heart Failure)
of patients with mild OSA and 69% of patients with severe OSA have hypertension (as per Sleep)
of type 2 diabetes sufferers have sleep apnea (as per Endocrine Practice) and that number jumps to 86% when patients are obese (as per Diabetes Care)
of stroke patients have sleep disordered breathing (as per Stroke)
In addition, Sleep notes that SDB is associated with a threefold increase in mortality risk and PLOS Medicine reports that severe sleep apnea raises sufferers’ death risk by 46%. By partnering with Sleep Data to treat OSA early, physicians can help ensure patients do not become part of those troublesome statistics.
Sleep Data’s proprietary technology platform, Clarity, allows care providers, patients, payers, and administrators unprecedented visibility and accountability into the care patients are receiving. It also allows for the highest quality service to be provided in a scalable and cost effective manner. We provide a level of visibility and accountability that no other vendor can match. Our technology platform allows for the “phenotyping” of PAP patients, the categorization of patients into cohorts based on their compliance patterns, and the real-time identification of those who are struggling and may be good candidates for an alternate form of therapy.